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provided sufﬁcient protection against moderate and severe
disease. Probability of breakthrough varicella was increased
when a interval since vaccination was longer.
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Background: The commonly used drugs against T. cruzi
are nifurtimox and benznidazole but they both have adverse
effects for humans. Clinical symptoms of Chagas disease also
depends on the strain present in each region. Drug screening
methods are tedious and expensive. High-throughput sys-
tems are required for screening anti-T. cruzi agents. The
use of transfected parasites expressing reporter genes like
ˇ-galactosidase has facilitated drug screening. However,
luciferase (luc) has a higher sensibility. In our studies we
found clinical and serological differences between the Peru-
vian and Bolivian strain. The Bolivian strain seems more
virulent as it has been documented with a high number
of acute and chronic cases. Here we developed transgenic
parasites expressing luciferase gene for having a new drug
screening method.
Methods: Bolivian strain (DH29) was isolated from a child
who acquired Chagas Disease by congenital infection based
on microscopic examination and parasites were recovered
by in vitro cultivation. The open reading frame of luc was
inserted in two vectors: pBS:CL-Neo-01/BC-LacZ-10 (pLAC)
and pTREX. Stable transfectans were isolated with G418 fol-
lowing integration of the circular transforming plasmids into
the nucleus of epimastigotes by electroporation. Luciferase
was detected by PCR, western blot and its activity with a
luminometer.
Results: Two plasmids were developed pBS-Neo-Luc and
pR-Luc-Neo. Drug (G418)- resistant parasites were iso-
lated after three weeks post electroporation. PCR (1.7Kb)
and western blot (61 KD) detected luciferase gene. Trans-
fected parasites incubated with luciferin showed luciferase
activity. The clones that failed to express luciferase were
found to have integrated the neomicin gene. The clones
that expressed luciferase were stable for more than six
months without selection. Two clones (L95 y L97) expressing
luciferase were isolated from DH29 strain. There is a correla-
tion between the enzyme activity and number of parasites.
Luciferase assay was able to detect 102 parasites ml-1.
Conclusion: The constructed plasmids pBS-Neo-Luc and el
pR-Luc-Neo are useful for stable expression in T. cruzi. Two
clones L95 and L97 from DH29 strain of T. cruzi expressing
luciferase gene were developed.There is a linear correlation
between luciferase activity and the number of parasites ml-
1. Luciferase assay is able to detect at least 102 parásitos
ml-1.doi:10.1016/j.ijid.2010.02.603ts e443
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Background: Breakthrough varicella rates range from 10
o 33%, it may be related to the regional epidemiolgy of vari-
ella. In this study, we investigated that the effectiveness
f varicella vaccine in vaccinated children who had received
single dose.
Methods: This study was conducted in 4 elementary
chools and 9 nursery schools in Izmir in Turkey between
ctober 1 and December 31, 2008. We distributed a ques-
ionnaire to parents and above to collect vaccination history
nd varicella disease. Varicella disease was deﬁned as an
cute, pruritic, generalized, maculopapulovesicular rash
ithout other apparent cause and it was deﬁned as vari-
ella like rash that developed >6 weeks after vaccination in
accinated children.
Results: In the study, 3630 questionnaire were distributed
nd 2523 of them were resumed. One thousand three hun-
red and eighty-four children who had received a single dose
f vaccine were included the study. Exclusion criteria were:
xistence of incomplete questionnaire and the children who
ere vaccinated with two doses. The varicella history was
etermined in 424 patients (30.7%) among patients who
eceived a single dose of vaccine. The mild form of varicella
as found to be 65.8%, and the moderate-severe type of dis-
ase was determined in 34.2% of in this patients. The disease
as diagnosed in 90 percent by a doctor. The median age of
hildren was 95 months and the median age at vaccination
as 13 months. According to the duration of vaccination, the
aricella disease rate was found 15% (<5 years), and 38.4%
≥5 years). Children who had been vaccinated 10 years or
ore were at greater risk for varicella disease (71%) than
hose who had been vaccinated the more recently.
Conclusion: A single dose of varicella vaccination pro-
ided poor protection against varicella, however the vaccine
